FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2779045392> ?p ?o ?g. }

• W2779045392 endingPage "641" @default.
• W2779045392 startingPage "631" @default.
• W2779045392 abstract "We compared the efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. Our outcomes were: recovery time from second twitch to train-of-four ratio > 0.9; recovery time from post-tetanic count 1-5 to train-of-four ratio > 0.9; and risk of composite adverse and serious adverse events. We searched for randomised clinical trials irrespective of publication status and date, blinding status, outcomes reported or language. We included 41 studies with 4206 participants. Time to reversal of neuromuscular blockade from second twitch to a train-of-four ratio > 0.9 was 2.0 min with sugammadex 2 mg.kg-1 and 12.9 min with neostigmine 0.05 mg.kg-1 , with a mean difference (MD) (95%CI)) of 10.2 (8.5-12.0) (I2 = 84%, 10 studies, n = 835, Grades of Recommendation, Assessment, Development and Evaluation (GRADE): moderate quality). Time to reversal of neuromuscular blockade from a post-tetanic count of 1-5 to a train-of-four ratio > 0.9 was 2.9 min with sugammadex 4 mg.kg-1 and 48.8 min with neostigmine 0.07 mg.kg-1 , with a MD (95%CI) of 45.8 (39.4-52.2) (I2 = 0%, 2 studies, n = 114, GRADE: low quality). There were significantly fewer composite adverse events in the sugammadex group compared with neostigmine, with a risk ratio (95%CI) of 0.60 (0.49-0.74) (I2 = 40%, 28 studies, n = 2298, number needed to treat (NNT): 8, GRADE: moderate quality). Specifically, the risk of bradycardia (RR (95%CI) 0.16 (0.07-0.34), n = 1218, NNT: 14, GRADE: moderate quality), postoperative nausea and vomiting (RR (95%CI) 0.52 (0.28-0.97), n = 389, NNT: 16, GRADE: low quality) and overall signs of postoperative residual paralysis (RR (95%CI) 0.40 (0.28-0.57), n = 1474, NNT: 13, GRADE: moderate quality) were all reduced. There was no significant difference regarding the risk of serious adverse events (RR 0.54, 95%CI 0.13-2.25, I2 = 0%, n = 959, GRADE: low quality). Sugammadex reverses neuromuscular blockade more rapidly than neostigmine and is associated with fewer adverse events." @default.
• W2779045392 created "2018-01-05" @default.
• W2779045392 creator A5018963132 @default.
• W2779045392 creator A5031600696 @default.
• W2779045392 creator A5040905987 @default.
• W2779045392 creator A5069883602 @default.
• W2779045392 date "2017-12-27" @default.
• W2779045392 modified "2023-10-01" @default.
• W2779045392 title "The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis" @default.
• W2779045392 cites W1801414640 @default.
• W2779045392 cites W1968706118 @default.
• W2779045392 cites W1981423065 @default.
• W2779045392 cites W1983844185 @default.
• W2779045392 cites W2011765774 @default.
• W2779045392 cites W2015847732 @default.
• W2779045392 cites W2016601631 @default.
• W2779045392 cites W2019322190 @default.
• W2779045392 cites W2021310216 @default.
• W2779045392 cites W2026344153 @default.
• W2779045392 cites W2030142935 @default.
• W2779045392 cites W2040443239 @default.
• W2779045392 cites W2044173572 @default.
• W2779045392 cites W2045332614 @default.
• W2779045392 cites W2055469806 @default.
• W2779045392 cites W2066662207 @default.
• W2779045392 cites W2072286744 @default.
• W2779045392 cites W2072883598 @default.
• W2779045392 cites W2078013938 @default.
• W2779045392 cites W2081947716 @default.
• W2779045392 cites W2082385062 @default.
• W2779045392 cites W2082585632 @default.
• W2779045392 cites W2082753953 @default.
• W2779045392 cites W2096651959 @default.
• W2779045392 cites W2100786429 @default.
• W2779045392 cites W2114205538 @default.
• W2779045392 cites W2117195234 @default.
• W2779045392 cites W2119616474 @default.
• W2779045392 cites W2128488589 @default.
• W2779045392 cites W2137360016 @default.
• W2779045392 cites W2143608063 @default.
• W2779045392 cites W2147672457 @default.
• W2779045392 cites W2147852875 @default.
• W2779045392 cites W2154937950 @default.
• W2779045392 cites W2156098321 @default.
• W2779045392 cites W2165010366 @default.
• W2779045392 cites W2166148391 @default.
• W2779045392 cites W2166843346 @default.
• W2779045392 cites W2173315374 @default.
• W2779045392 cites W2181438675 @default.
• W2779045392 cites W2189448871 @default.
• W2779045392 cites W2244356355 @default.
• W2779045392 cites W2279794985 @default.
• W2779045392 cites W2296447700 @default.
• W2779045392 cites W2312214738 @default.
• W2779045392 cites W2317633893 @default.
• W2779045392 cites W2322970438 @default.
• W2779045392 cites W2325662153 @default.
• W2779045392 cites W2327654344 @default.
• W2779045392 cites W2329727661 @default.
• W2779045392 cites W2332539973 @default.
• W2779045392 cites W2335510222 @default.
• W2779045392 cites W2337941001 @default.
• W2779045392 cites W2472037314 @default.
• W2779045392 cites W2529597016 @default.
• W2779045392 cites W2535020974 @default.
• W2779045392 cites W2546985081 @default.
• W2779045392 cites W2560031487 @default.
• W2779045392 cites W2568964326 @default.
• W2779045392 cites W2587800844 @default.
• W2779045392 cites W2621142169 @default.
• W2779045392 cites W2736187258 @default.
• W2779045392 cites W2991792334 @default.
• W2779045392 cites W4255666079 @default.
• W2779045392 doi "https://doi.org/10.1111/anae.14160" @default.
• W2779045392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29280475" @default.
• W2779045392 hasPublicationYear "2017" @default.
• W2779045392 type Work @default.
• W2779045392 sameAs 2779045392 @default.
• W2779045392 citedByCount "104" @default.
• W2779045392 countsByYear W27790453922018 @default.
• W2779045392 countsByYear W27790453922019 @default.
• W2779045392 countsByYear W27790453922020 @default.
• W2779045392 countsByYear W27790453922021 @default.
• W2779045392 countsByYear W27790453922022 @default.
• W2779045392 countsByYear W27790453922023 @default.
• W2779045392 crossrefType "journal-article" @default.
• W2779045392 hasAuthorship W2779045392A5018963132 @default.
• W2779045392 hasAuthorship W2779045392A5031600696 @default.
• W2779045392 hasAuthorship W2779045392A5040905987 @default.
• W2779045392 hasAuthorship W2779045392A5069883602 @default.
• W2779045392 hasBestOaLocation W27790453921 @default.
• W2779045392 hasConcept C126322002 @default.
• W2779045392 hasConcept C142724271 @default.
• W2779045392 hasConcept C197934379 @default.
• W2779045392 hasConcept C204787440 @default.
• W2779045392 hasConcept C27081682 @default.
• W2779045392 hasConcept C2771230 @default.
• W2779045392 hasConcept C2776277131 @default.

• next